Kyeong Tae Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kyeong Tae Kim has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
J. Geoffrey Chase
Centre for Bioengineering, University of Canterbury, Christchurch, New Zealand
3 shared publicationsJennifer Knopp
Centre for Bioengineering, University of Canterbury, Christchurch, New Zealand
3 shared publicationsBronwyn Dixon
Neonatal Intensive Care Unit, Christchurch Women’s Hospital, Christchurch, New Zealand
2 shared publicationsGeoffrey M. Shaw
Department of Intensive Care, Christchurch Hospital, Private Bag 4710, Christchurch, New Zealand
2 shared publicationsAkos Szlavecz
Department of Control Engineering and Information, Budapest University of Technology and Economics, Budapest, Hungary
1 shared publicationBalazs Benyo
Department of Control Engineering and Information, Budapest University of Technology and Economics, Budapest, Hungary
1 shared publication
Latest Publications
- 19 January 2022
- Published by Springer Nature in Medical & Biological Engineering & Computing
- Vol. 60 (3) , 739-751
Quantifying neonatal patient effort using non-invasive model-based methods
Patient-specific spontaneous breathing effort (SB) is common in invasively mechanically ventilated (MV) adult patients, and especially common in preterm neonates who are not typically sedated. However, there is no proven, ethically feasible and non-invasive method to quantify SB effort in neonates, creating the potential for model-based measures. Lung mechanics and SB effort are segregated using a basis function model to identify passive lung mechanics, and an additional time-varying elastance model to identify patient-specific SB effort and asynchrony as negative and positive added elastances, respectively. Data from ten preterm neonates on standard MV care in the neonatal intensive care unit (NICU) are used to assess this model-based approach, using area under the curve (AUC) for positive (asynchrony) and negative (SB effort) time-varying elastance. Median [interquartile-range (IQR)] of passive pulmonary lung elastance was 3.82 [2.09—5.80] cmH2O/ml. Median [IQR] AUC quantified SB effort was -0.32 [-0.43—-0.12]cmH2O/ml. AUC quantified asynchrony was 0.00 [0.00—0.01]cmH2O/ml, and affected 28% of the 25,287 total breaths. This proof of concept model-based approach provides a non-invasive, computationally straightforward, and thus clinically feasible means to quantify patient-specific spontaneous breathing effort and asynchrony. Graphical abstract
- 19 January 2022
- Published by Springer Nature in Medical & Biological Engineering & Computing
- Vol. 60 (3) , 739-751
Quantifying neonatal patient effort using non-invasive model-based methods
Patient-specific spontaneous breathing effort (SB) is common in invasively mechanically ventilated (MV) adult patients, and especially common in preterm neonates who are not typically sedated. However, there is no proven, ethically feasible and non-invasive method to quantify SB effort in neonates, creating the potential for model-based measures. Lung mechanics and SB effort are segregated using a basis function model to identify passive lung mechanics, and an additional time-varying elastance model to identify patient-specific SB effort and asynchrony as negative and positive added elastances, respectively. Data from ten preterm neonates on standard MV care in the neonatal intensive care unit (NICU) are used to assess this model-based approach, using area under the curve (AUC) for positive (asynchrony) and negative (SB effort) time-varying elastance. Median [interquartile-range (IQR)] of passive pulmonary lung elastance was 3.82 [2.09—5.80] cmH2O/ml. Median [IQR] AUC quantified SB effort was -0.32 [-0.43—-0.12]cmH2O/ml. AUC quantified asynchrony was 0.00 [0.00—0.01]cmH2O/ml, and affected 28% of the 25,287 total breaths. This proof of concept model-based approach provides a non-invasive, computationally straightforward, and thus clinically feasible means to quantify patient-specific spontaneous breathing effort and asynchrony. Graphical abstract
- 1 September 2021
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 208, 106300
Model-based estimation of negative inspiratory driving pressure in patients receiving invasive NAVA mechanical ventilation
- 1 September 2021
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 208, 106300
Model-based estimation of negative inspiratory driving pressure in patients receiving invasive NAVA mechanical ventilation
- Open Access
- 1 February 2020
- Published by Springer Nature in Trials
- Vol. 21 (1) , 1-18
Model-based PEEP titration versus standard practice in mechanical ventilation: a randomised controlled trial
Background: Positive end-expiratory pressure (PEEP) at minimum respiratory elastance during mechanical ventilation (MV) in patients with acute respiratory distress syndrome (ARDS) may improve patient care and outcome. The Clinical utilisation of respiratory elastance (CURE) trial is a two-arm, randomised controlled trial (RCT) investigating the performance of PEEP selected at an objective, model-based minimal respiratory system elastance in patients with ARDS. Methods and design: The CURE RCT compares two groups of patients requiring invasive MV with a partial pressure of arterial oxygen/fraction of inspired oxygen (PaO2/FiO2) ratio ≤ 200; one criterion of the Berlin consensus definition of moderate (≤ 200) or severe (≤ 100) ARDS. All patients are ventilated using pressure controlled (bi-level) ventilation with tidal volume = 6–8 ml/kg. Patients randomised to the control group will have PEEP selected per standard practice (SPV). Patients randomised to the intervention will have PEEP selected based on a minimal elastance using a model-based computerised method. The CURE RCT is a single-centre trial in the intensive care unit (ICU) of Christchurch hospital, New Zealand, with a target sample size of 320 patients over a maximum of 3 years. The primary outcome is the area under the curve (AUC) ratio of arterial blood oxygenation to the fraction of inspired oxygen over time. Secondary outcomes include length of time of MV, ventilator-free days (VFD) up to 28 days, ICU and hospital length of stay, AUC of oxygen saturation (SpO2)/FiO2 during MV, number of desaturation events (SpO2 < 88%), changes in respiratory mechanics and chest x-ray index scores, rescue therapies (prone positioning, nitric oxide use, extracorporeal membrane oxygenation) and hospital and 90-day mortality. Discussion: The CURE RCT is the first trial comparing significant clinical outcomes in patients with ARDS in whom PEEP is selected at minimum elastance using an objective model-based method able to quantify and consider both inter-patient and intra-patient variability. CURE aims to demonstrate the hypothesized benefit of patient-specific PEEP and attest to the significance of real-time monitoring and decision-support for MV in the critical care environment. Trial registration: Australian New Zealand Clinical Trial Registry, ACTRN12614001069640. Registered on 22 September 2014. (https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366838&isReview=true) The CURE RCT clinical protocol and data usage has been granted by the New Zealand South Regional Ethics Committee (Reference number: 14/STH/132).
- 1 February 2020
- Published by Springer Nature in Trials
- Vol. 21 (1) , 1-18
Open AccessModel-based PEEP titration versus standard practice in mechanical ventilation: a randomised controlled trial
Background: Positive end-expiratory pressure (PEEP) at minimum respiratory elastance during mechanical ventilation (MV) in patients with acute respiratory distress syndrome (ARDS) may improve patient care and outcome. The Clinical utilisation of respiratory elastance (CURE) trial is a two-arm, randomised controlled trial (RCT) investigating the performance of PEEP selected at an objective, model-based minimal respiratory system elastance in patients with ARDS. Methods and design: The CURE RCT compares two groups of patients requiring invasive MV with a partial pressure of arterial oxygen/fraction of inspired oxygen (PaO2/FiO2) ratio ≤ 200; one criterion of the Berlin consensus definition of moderate (≤ 200) or severe (≤ 100) ARDS. All patients are ventilated using pressure controlled (bi-level) ventilation with tidal volume = 6–8 ml/kg. Patients randomised to the control group will have PEEP selected per standard practice (SPV). Patients randomised to the intervention will have PEEP selected based on a minimal elastance using a model-based computerised method. The CURE RCT is a single-centre trial in the intensive care unit (ICU) of Christchurch hospital, New Zealand, with a target sample size of 320 patients over a maximum of 3 years. The primary outcome is the area under the curve (AUC) ratio of arterial blood oxygenation to the fraction of inspired oxygen over time. Secondary outcomes include length of time of MV, ventilator-free days (VFD) up to 28 days, ICU and hospital length of stay, AUC of oxygen saturation (SpO2)/FiO2 during MV, number of desaturation events (SpO2 < 88%), changes in respiratory mechanics and chest x-ray index scores, rescue therapies (prone positioning, nitric oxide use, extracorporeal membrane oxygenation) and hospital and 90-day mortality. Discussion: The CURE RCT is the first trial comparing significant clinical outcomes in patients with ARDS in whom PEEP is selected at minimum elastance using an objective model-based method able to quantify and consider both inter-patient and intra-patient variability. CURE aims to demonstrate the hypothesized benefit of patient-specific PEEP and attest to the significance of real-time monitoring and decision-support for MV in the critical care environment. Trial registration: Australian New Zealand Clinical Trial Registry, ACTRN12614001069640. Registered on 22 September 2014. (https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366838&isReview=true) The CURE RCT clinical protocol and data usage has been granted by the New Zealand South Regional Ethics Committee (Reference number: 14/STH/132).
- 1 January 2020
- Published by Elsevier in IFAC-PapersOnLine
- Vol. 53 (2) , 16173-16178
Physiological sex differences in mechanically ventilated premature neonates: A pilot study
- 1 January 2020
- Published by Elsevier in IFAC-PapersOnLine
- Vol. 53 (2) , 16173-16178
Physiological sex differences in mechanically ventilated premature neonates: A pilot study
- 9 October 2019
- Published by Wiley in Pediatric Pulmonology
- Vol. 55 (1) , 177-184
Mechanically ventilated premature babies have sex differences in specific elastance: A pilot study
Objectives: A pilot study to compare pulmonary mechanics in a neonatal intensive care unit (NICU) cohort, specifically, comparing lung elastance between male and female infants in the NICU.Hypothesis: Anecdotally, male infants are harder to ventilate than females. We hypothesize that males have higher model‐based elastance (converse: lower specific compliance) compared to females, reflecting underlying stiffer lungs.Study Design: A clinically validated, single‐compartment model is used to identify specific elastance (inverse of specific compliance) and resistance for each breath. Specific elastance accounts for weight differences when comparing male and female infants. Relative percent breath‐to‐breath variability (%ΔE) in specific elastance is also compared. Level of asynchrony was also determined.Patient‐subject Selection: Ten invasively mechanically ventilated patients from Christchurch Women's Hospital.Methodology: Airway pressure and flow data from 10 invasive mechanical ventilation (MV) infants from Christchurch Women's Hospital Neonatal Intensive Care Unit, New Zealand was prospectively recorded under standard MV care. Model‐based specific elastance and resistance are identified for each breath, as well as relative percent breath‐to‐breath variability (%ΔE) in specific elastance.Results: Male infants overall had higher specific elastance compared to females infants (P ≤ .01), with median (interquartile range) for males of 1.91 (1.33‐2.48) cmH2O·kg/mL compared to 1.31 (0.86‐2.02) cmH2O·kg/mL in females. Male infants had lower variability with %ΔE of −0.03 (−7.56 to 8.01)% vs female infants of −0.59 (12.56‐12.86)%. Males had 14.75% asynchronous breaths whereas females had 17.54%.Conclusion: Overall, males had higher specific elastance and correspondingly lower breath‐to‐breath variability. These results indicate male and female infants may require different MV settings, mode, and monitoring.
- 9 October 2019
- Published by Wiley in Pediatric Pulmonology
- Vol. 55 (1) , 177-184
Mechanically ventilated premature babies have sex differences in specific elastance: A pilot study
Objectives: A pilot study to compare pulmonary mechanics in a neonatal intensive care unit (NICU) cohort, specifically, comparing lung elastance between male and female infants in the NICU.Hypothesis: Anecdotally, male infants are harder to ventilate than females. We hypothesize that males have higher model‐based elastance (converse: lower specific compliance) compared to females, reflecting underlying stiffer lungs.Study Design: A clinically validated, single‐compartment model is used to identify specific elastance (inverse of specific compliance) and resistance for each breath. Specific elastance accounts for weight differences when comparing male and female infants. Relative percent breath‐to‐breath variability (%ΔE) in specific elastance is also compared. Level of asynchrony was also determined.Patient‐subject Selection: Ten invasively mechanically ventilated patients from Christchurch Women's Hospital.Methodology: Airway pressure and flow data from 10 invasive mechanical ventilation (MV) infants from Christchurch Women's Hospital Neonatal Intensive Care Unit, New Zealand was prospectively recorded under standard MV care. Model‐based specific elastance and resistance are identified for each breath, as well as relative percent breath‐to‐breath variability (%ΔE) in specific elastance.Results: Male infants overall had higher specific elastance compared to females infants (P ≤ .01), with median (interquartile range) for males of 1.91 (1.33‐2.48) cmH2O·kg/mL compared to 1.31 (0.86‐2.02) cmH2O·kg/mL in females. Male infants had lower variability with %ΔE of −0.03 (−7.56 to 8.01)% vs female infants of −0.59 (12.56‐12.86)%. Males had 14.75% asynchronous breaths whereas females had 17.54%.Conclusion: Overall, males had higher specific elastance and correspondingly lower breath‐to‐breath variability. These results indicate male and female infants may require different MV settings, mode, and monitoring.